United States Parkinson's Disease Drug Market Research Report Forecast 2017-2021

August 2017 | 104 pages | ID: U8ED96FA42AEN
S&P Consulting

Abstracts

The United States Parkinson's Disease Drug Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Parkinson's Disease Drug industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Parkinson's Disease Drug market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

The Major players reported in the market include:

Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical
Abbvie
Akorn
Astellas Pharma
Desitin Arzneimittel
Endo International

United States Parkinson's Disease Drug Market: Product Segment Analysis

Type 1
Type 2
Type 3

United States Parkinson's Disease Drug Market: Application Segment Analysis

Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 PARKINSON'S DISEASE DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Parkinson's Disease Drug
1.2 Parkinson's Disease Drug Market Segmentation by Type
  1.2.1 United States Production Market Share of Parkinson's Disease Drug by Type in 2015
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Parkinson's Disease Drug Market Segmentation by Application
  1.3.1 Parkinson's Disease Drug Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Parkinson's Disease Drug (2011-2021)

CHAPTER 2 UNITED STATES ECONOMIC IMPACT ON PARKINSON'S DISEASE DRUG INDUSTRY

2.1 United States Macroeconomic Analysis
2.2 United States Macroeconomic Environment Development Trend

CHAPTER 3 UNITED STATES PARKINSON'S DISEASE DRUG MARKET COMPETITION BY MANUFACTURERS

3.1 United States Parkinson's Disease Drug Production and Share by Manufacturers (2015 and 2016)
3.2 United States Parkinson's Disease Drug Revenue and Share by Manufacturers (2015 and 2016)
3.3 United States Parkinson's Disease Drug Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Parkinson's Disease Drug Manufacturing Base Distribution, Production Area and Product Type
3.5 Parkinson's Disease Drug Market Competitive Situation and Trends
  3.5.1 Parkinson's Disease Drug Market Concentration Rate
  3.5.2 Parkinson's Disease Drug Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 UNITED STATES PARKINSON'S DISEASE DRUG PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 United States Parkinson's Disease Drug Production and Market Share by Type (2012-2017)
4.2 United States Parkinson's Disease Drug Revenue and Market Share by Type (2012-2017)
4.3 United States Parkinson's Disease Drug Price by Type (2012-2017)
4.4 United States Parkinson's Disease Drug Production Growth by Type (2012-2017)

CHAPTER 5 UNITED STATES PARKINSON'S DISEASE DRUG MARKET ANALYSIS BY APPLICATION

5.1 United States Parkinson's Disease Drug Consumption and Market Share by Application (2012-2017)
5.2 United States Parkinson's Disease Drug Consumption Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
  5.3.1 Potential Applications
  5.3.2 Emerging Markets/Countries

CHAPTER 6 UNITED STATES PARKINSON'S DISEASE DRUG MANUFACTURERS ANALYSIS

6.1 Boehringer Ingelheim
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Product Type, Application and Specification
  6.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Business Overview
6.2 GlaxoSmithKline
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Product Type, Application and Specification
  6.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Business Overview
6.3 Novartis
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Product Type, Application and Specification
  6.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Business Overview
6.4 Teva Pharmaceutical
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Product Type, Application and Specification
  6.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Business Overview
6.5 Abbvie
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Product Type, Application and Specification
  6.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Business Overview
6.6 Akorn
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.7 Astellas Pharma
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Product Type, Application and Specification
  6.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Business Overview
6.8 Desitin Arzneimittel
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Product Type, Application and Specification
  6.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Business Overview
6.9 Endo International
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Product Type, Application and Specification
  6.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Business Overview

…

CHAPTER 7 PARKINSON'S DISEASE DRUG MANUFACTURING COST ANALYSIS

7.1 Parkinson's Disease Drug Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Parkinson's Disease Drug

CHAPTER 8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Parkinson's Disease Drug Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Parkinson's Disease Drug Major Manufacturers in 2015
8.4 Downstream Buyers

CHAPTER 9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

CHAPTER 10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

CHAPTER 11 UNITED STATES PARKINSON'S DISEASE DRUG MARKET FORECAST (2017-2021)

11.1 United States Parkinson's Disease Drug Production, Revenue Forecast (2017-2021)
11.2 United States Parkinson's Disease Drug Production, Consumption Forecast by Regions (2017-2021)
11.3 United States Parkinson's Disease Drug Production Forecast by Type (2017-2021)
11.4 United States Parkinson's Disease Drug Consumption Forecast by Application (2017-2021)
11.5 Parkinson's Disease Drug Price Forecast (2017-2021)

CHAPTER 12 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Parkinson's Disease Drug
Table Classification of Parkinson's Disease Drug
Figure United States Sales Market Share of Parkinson's Disease Drug by Type in 2015
Table Application of Parkinson's Disease Drug
Figure United States Sales Market Share of Parkinson's Disease Drug by Application in 2015
Figure United States Parkinson's Disease Drug Sales and Growth Rate (2011-2021)
Figure United States Parkinson's Disease Drug Revenue and Growth Rate (2011-2021)
Table United States Parkinson's Disease Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Parkinson's Disease Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Parkinson's Disease Drug Sales Share by Manufacturers
Figure 2016 Parkinson's Disease Drug Sales Share by Manufacturers
Table United States Parkinson's Disease Drug Revenue by Manufacturers (2015 and 2016)
Table United States Parkinson's Disease Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Parkinson's Disease Drug Revenue Share by Manufacturers
Table 2016 United States Parkinson's Disease Drug Revenue Share by Manufacturers
Table United States Market Parkinson's Disease Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Parkinson's Disease Drug Average Price of Key Manufacturers in 2015
Figure Parkinson's Disease Drug Market Share of Top 3 Manufacturers
Figure Parkinson's Disease Drug Market Share of Top 5 Manufacturers
Table United States Parkinson's Disease Drug Sales by Type (2012-2017)
Table United States Parkinson's Disease Drug Sales Share by Type (2012-2017)
Figure United States Parkinson's Disease Drug Sales Market Share by Type in 2015
Table United States Parkinson's Disease Drug Revenue and Market Share by Type (2012-2017)
Table United States Parkinson's Disease Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Parkinson's Disease Drug by Type (2012-2017)
Table United States Parkinson's Disease Drug Price by Type (2012-2017)
Figure United States Parkinson's Disease Drug Sales Growth Rate by Type (2012-2017)
Table United States Parkinson's Disease Drug Sales by Application (2012-2017)
Table United States Parkinson's Disease Drug Sales Market Share by Application (2012-2017)
Figure United States Parkinson's Disease Drug Sales Market Share by Application in 2015
Table United States Parkinson's Disease Drug Sales Growth Rate by Application (2012-2017)
Figure United States Parkinson's Disease Drug Sales Growth Rate by Application (2012-2017)
Table Boehringer Ingelheim Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Boehringer Ingelheim Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Boehringer Ingelheim Parkinson's Disease Drug Market Share (2012-2017)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Production Area and Its Competitors
Table GlaxoSmithKline Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table GlaxoSmithKline Parkinson's Disease Drug Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Parkinson's Disease Drug Market Share (2012-2017)
Table Teva Pharmaceutical Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Teva Pharmaceutical Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Teva Pharmaceutical Parkinson's Disease Drug Market Share (2012-2017)
Table Abbvie Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Abbvie Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Abbvie Parkinson's Disease Drug Market Share (2012-2017)
Table Akorn Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Akorn Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Akorn Parkinson's Disease Drug Market Share (2012-2017)
Table Astellas Pharma Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Astellas Pharma Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Astellas Pharma Parkinson's Disease Drug Market Share (2012-2017)
Table Desitin Arzneimittel Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Desitin Arzneimittel Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Desitin Arzneimittel Parkinson's Disease Drug Market Share (2012-2017)
Table Endo International Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Endo International Parkinson's Disease Drug Production, Revenue, Price and Gross Margin (2012-2017)
Table Endo International Parkinson's Disease Drug Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Parkinson's Disease Drug
Figure Manufacturing Process Analysis of Parkinson's Disease Drug
Figure Parkinson's Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Parkinson's Disease Drug Major Manufacturers in 2015
Table Major Buyers of Parkinson's Disease Drug
Table Distributors/Traders List
Figure United States Parkinson's Disease Drug Production and Growth Rate Forecast (2017-2021)
Figure United States Parkinson's Disease Drug Revenue and Growth Rate Forecast (2017-2021)
Table United States Parkinson's Disease Drug Production Forecast by Type (2017-2021)
Table United States Parkinson's Disease Drug Consumption Forecast by Application (2017-2021)